Pathophysiology of schizophrenia: Dopamine hypothesis

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 8, Issue 2, 1996, Pages 222-

  Neylan, Thomas C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; NEUROLEPTIC AGENT;

HUMAN; HYPOTHESIS; PRIORITY JOURNAL; SCHIZOPHRENIA; SHORT SURVEY;

EID: 19144373473     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.8.2.222     Document Type: Short Survey

References (8)

1. Connell PH: Amphetamine Psychosis (Maudsley Monograph no 5). London, Oxford University Press, 1958
2. Carlsson A, Lindqvist M: Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxidol 1963; 20:140-144
3. Angrist BM, Gerson S: The phenomenology of experimentally induced amphetamine psychosis: preliminary observations. Biol Psychiatry 1970; 2:95-107
4. Griffith JD, Cavanaugh J, Held J, et al: Dextroamphetamine: evaluation of psychomimetic properties in man. Arch Gen Psychiatry 1972; 26:97-100
5. Snyder SH: Catecholamines in the brain as mediators of amphetamine psychosis. Arch Gen Psychiatry 1972; 27:169-179
6. Sathananthan G, Angrist BM, Gerson S: Response threshold to levodopa in psychiatric patients. Biol Psychiatry 1973; 7:139-146
7. Seeman P, Lee T: Antipsychotic drugs: direct correlation between clinical potency and presynaptic action of dopamine neurons. Science 1975; 188:1217-1219
8. Seeman P, Lee T, Chau-Wong M, et al: Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 1976; 261:717-719